| Dr Osvaldo A Schirripa, MD | |
|
143 Sw Shevlin Hixon Dr, Suite #203, Bend, OR 97702-3189 | |
| (541) 633-7172 | |
| Not Available |
| Full Name | Dr Osvaldo A Schirripa |
|---|---|
| Gender | Male |
| Speciality | Medical Genetics - Clinical Genetics (m.d.) |
| Location | 143 Sw Shevlin Hixon Dr, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336264373 | NPI | - | NPPES |
| Entity Name | Central Oregon Clinical Genetics Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740572221 PECOS PAC ID: 8224216585 Enrollment ID: O20110711000223 |
News Archive
To kick-off the New Year in a healthy way, Judy Gelinas, director of the St. Christopher's Foundation for Children's Community Oral Health Initiative, recommends that local parents have their children adopt the following three practices in 2010 as part of their New Year's Resolution
With a $25 million grant from an anonymous donor, the University of Michigan will begin training doctors in Africa in reproductive health services not widely available to many women living in remote areas of the continent.
DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC, for the first quarter ended March 29, 2014.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Osvaldo A Schirripa, MD 143 Sw Shevlin Hixon Dr, Suite #203, Bend, OR 97702-3189 Ph: (541) 633-7172 | Dr Osvaldo A Schirripa, MD 143 Sw Shevlin Hixon Dr, Suite #203, Bend, OR 97702-3189 Ph: (541) 633-7172 |
News Archive
To kick-off the New Year in a healthy way, Judy Gelinas, director of the St. Christopher's Foundation for Children's Community Oral Health Initiative, recommends that local parents have their children adopt the following three practices in 2010 as part of their New Year's Resolution
With a $25 million grant from an anonymous donor, the University of Michigan will begin training doctors in Africa in reproductive health services not widely available to many women living in remote areas of the continent.
DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC, for the first quarter ended March 29, 2014.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.
› Verified 1 days ago